Company Name: |
DC Chemicals
|
Tel: |
021-58447131 13564518121 |
Email: |
sales@dcchemicals.com |
Products Intro: |
Product Name:M1002 CAS:823830-85-9 Purity:98% HPLC Package:100mg,250mg,1g
|
Company Name: |
Bide Pharmatech Ltd.
|
Tel: |
400-1647117 13681763483 |
Email: |
product02@bidepharm.com |
Products Intro: |
Product Name:3-((3,5-Bis(trifluoromethyl)phenyl)amino)benzo[d]isothiazole 1,1-dioxide CAS:823830-85-9 Purity:98% Package:25mg;50mg;100mg;250mg;1g; Remarks:BD01496580
|
Company Name: |
TargetMol Chemicals Inc.
|
Tel: |
4008200310 |
Email: |
marketing@tsbiochem.com |
Products Intro: |
Product Name:M1002 CAS:823830-85-9 Purity:99.73% Package:1mg/RMB 488;5mg/RMB 1080;10mg/RMB 1570
|
Company Name: |
Suzhou Zhixin Biotechnology Co., Ltd.
|
Tel: |
0512-65118909 15162312715 |
Email: |
sales@szzxbio.com |
Products Intro: |
Product Name:M1002 CAS:823830-85-9 Purity:98%+ Package:1g;10g;100g Remarks:1g
|
|
| N-[3,5-bis(trifluoromethyl)phenyl]-N-(1,1-dioxido-1,2-benzisothiazol-3-yl)amine Basic information |
Product Name: | N-[3,5-bis(trifluoromethyl)phenyl]-N-(1,1-dioxido-1,2-benzisothiazol-3-yl)amine | Synonyms: | N-[3,5-bis(trifluoromethyl)phenyl]-N-(1,1-dioxido-1,2-benzisothiazol-3-yl)amine;N-[3,5-bis(trifluoromethyl)phenyl]-1,2-benzothiazol-3-amine 1,1-dioxide;1,2-Benzisothiazol-3-amine, N-[3,5-bis(trifluoromethyl)phenyl]-, 1,1-dioxide;3-((3,5-Bis(trifluoromethyl)phenyl)amino)benzo[d]isothiazole 1,1-dioxide | CAS: | 823830-85-9 | MF: | C15H8F6N2O2S | MW: | 394.29 | EINECS: | | Product Categories: | | Mol File: | 823830-85-9.mol | |
| N-[3,5-bis(trifluoromethyl)phenyl]-N-(1,1-dioxido-1,2-benzisothiazol-3-yl)amine Chemical Properties |
Boiling point | 414.6±55.0 °C(Predicted) | density | 1.60±0.1 g/cm3(Predicted) | storage temp. | Store at -20°C | form | Solid | pka | -2.13±0.20(Predicted) | color | White to off-white |
| N-[3,5-bis(trifluoromethyl)phenyl]-N-(1,1-dioxido-1,2-benzisothiazol-3-yl)amine Usage And Synthesis |
Biological Activity | M1002 is a hypoxia-inducible factor-2 (HIF-2) agonist, and can enhance the expression of HIF-2 target genes. M1002 shows synergy with prolyl-hydroxylase domain (PHD) inhibitors[1].
M1002 (10 μM; 24 h) enhances the expression of HIF-2 target genes with great efficacy[1].M1002 (5 μM; 24 h) treatment shows synergy with prolyl hydroxylase domain (PHD) inhibitors[1]. | References | [1]. Dalei Wu, et al. Bidirectional modulation of HIF-2 activity through chemical ligands. Nat Chem Biol. 2019 Apr;15(4):367-376. |
| N-[3,5-bis(trifluoromethyl)phenyl]-N-(1,1-dioxido-1,2-benzisothiazol-3-yl)amine Preparation Products And Raw materials |
|